Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$9.38 - $20.29 $286,090 - $618,845
-30,500 Reduced 17.24%
146,415 $2.97 Million
Q3 2022

Nov 14, 2022

SELL
$9.52 - $13.48 $157,080 - $222,420
-16,500 Reduced 8.53%
176,915 $1.9 Million
Q2 2022

Aug 12, 2022

BUY
$10.12 - $23.32 $155,848 - $359,128
15,400 Added 8.65%
193,415 $2.32 Million
Q1 2022

May 13, 2022

SELL
$19.54 - $33.59 $113,332 - $194,822
-5,800 Reduced 3.16%
178,015 $3.81 Million
Q4 2021

Feb 11, 2022

SELL
$22.51 - $36.79 $490,718 - $802,022
-21,800 Reduced 10.6%
183,815 $6.18 Million
Q3 2021

Nov 12, 2021

BUY
$13.28 - $25.79 $189,904 - $368,797
14,300 Added 7.47%
205,615 $5.29 Million
Q2 2021

Aug 13, 2021

SELL
$10.5 - $14.19 $330,750 - $446,985
-31,500 Reduced 14.14%
191,315 $2.56 Million
Q1 2021

May 13, 2021

SELL
$8.2 - $14.49 $114,799 - $202,860
-14,000 Reduced 5.91%
222,815 $2.37 Million
Q4 2020

Feb 10, 2021

BUY
$6.87 - $8.88 $143,583 - $185,592
20,900 Added 9.68%
236,815 $1.9 Million
Q3 2020

Nov 13, 2020

BUY
$7.48 - $9.54 $209,028 - $266,595
27,945 Added 14.87%
215,915 $1.62 Million
Q2 2020

Aug 13, 2020

BUY
$8.64 - $11.87 $1.1 Million - $1.5 Million
126,742 Added 207.0%
187,970 $1.7 Million
Q1 2020

May 14, 2020

BUY
$9.11 - $14.42 $184,022 - $291,284
20,200 Added 49.23%
61,228 $587,000
Q4 2019

Feb 13, 2020

BUY
$13.16 - $15.96 $339,778 - $412,071
25,819 Added 169.76%
41,028 $591,000
Q3 2019

Nov 13, 2019

BUY
$11.26 - $16.48 $171,253 - $250,644
15,209 New
15,209 $229,000

Others Institutions Holding OPNT

About OPIANT PHARMACEUTICALS, INC.


  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.